SCHEMBL18642000

SCHEMBL18642000

CS(=O)(=O)c1[nH]c2ccccc2c1C[C@H](N)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 2/20 0.49
TSHR P16473 2/20 0.49
KMT2A Q03164 2/20 0.49
LMNA P02545 1/20 0.49
MPO P05164 1/20 0.49
BLM P54132 1/20 0.49
PMP22 Q01453 1/20 0.49
HIF1A Q16665 1/20 0.49
ALDH1A1 P00352 3/20 0.46
GAA P10253 1/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
EGFR P00533 3/20 0.46
SRC P12931 1/20 0.46
SCN9A Q15858 1/20 0.46
ALPI P09923 1/20 0.43
PKM P14618 1/20 0.43
PTGS1 P23219 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28569616 0.88 KDM4E (0.50) MAPTKDM4EMEN1TSHRKMT2A
SCHEMBL28569615 0.88 KDM4E (0.50) MAPTKDM4EMEN1TSHRKMT2A
SCHEMBL30678518 0.88 KDM4E (0.50) MAPTKDM4EMEN1TSHRKMT2A
SCHEMBL31161279 0.88 KDM4E (0.50) MAPTKDM4EMEN1TSHRKMT2A
SCHEMBL29499673 0.83 MAPT (0.61) MAPTKDM4EMEN1TSHRKMT2A
SCHEMBL4586167 0.83 MAPT (0.61) MAPTKDM4EMEN1TSHRKMT2A
SCHEMBL29557291 0.83 MAPT (0.61) MAPTKDM4EMEN1TSHRKMT2A
SCHEMBL2049320 0.83 MAPT (0.61) MAPTKDM4EMEN1TSHRKMT2A
SCHEMBL29527665 0.83 MAPT (0.61) MAPTKDM4EMEN1TSHRKMT2A
SCHEMBL195997 0.83 MAPT (0.61) MAPTKDM4EMEN1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4684030-A2 METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP Martin-Luther-Universität Halle-Wittenberg (DE) 2026-01-28 EP disclosed
WO-2024227957-A2 METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP Martin-Luther-Universität Halle-Wittenberg (DE) 2024-11-07 WO disclosed
CN-115181164-A Derivatives of amatoxins and their coupling to cell binding molecules 杭州多禧生物科技有限公司 2022-10-14 CN disclosed
CN-109689107-B Derivatives of amatoxins and their coupling to cell binding molecules 杭州多禧生物科技有限公司 2022-08-16 CN disclosed
US-10836796-B2 Derivatives of amanita toxins and their conjugation to a cell binding molecule HANGZHOU DAC BIOTECH CO., LTD. (CN) 2020-11-17 US disclosed
US-20200079820-A1 DERIVATIVES OF AMANITA TOXINS AND THEIR CONJUGATION TO A CELL BINDING MOLECULE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2020-03-12 US disclosed
WO-2017046658-A1 DERIVATIVES OF AMANITA TOXINS AND THEIR CONJUGATION TO A CELL BINDING MOLECULE HANGZHOU DAC BIOTECH CO, LTD (CN) 2017-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200079820-A1 DERIVATIVES OF AMANITA TOXINS AND THEIR CONJUGATION TO A CELL BINDING MOLECULE ANTXR2, ANXA5, C3AR1 MAPT 3010/4885KDM4E 3063/4885MEN1 260/4885
US-10836796-B2 Derivatives of amanita toxins and their conjugation to a cell binding molecule ANTXR2, ANXA5, C3AR1 MAPT 3086/4885KDM4E 2965/4885MEN1 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.